Proteome Sciences (LON:PRM) Trading Down 11% – Here’s What Happened

Proteome Sciences plc (LON:PRM) was down 11% during mid-day trading on Wednesday . The company traded as low as GBX 1.42 and last traded at GBX 1.42. Approximately 32,210 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 417,027 shares. The stock had previously closed at GBX 1.60.

Proteome Sciences Trading Up 4.4%

The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The company’s fifty day moving average is GBX 1.55 and its 200-day moving average is GBX 1.93. The stock has a market cap of £5.86 million, a PE ratio of -1.61 and a beta of 0.07.

Proteome Sciences (LON:PRM) last issued its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share (EPS) for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.The business had revenue of GBX 376 million for the quarter.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.